Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;288(6):614-624.
doi: 10.1111/joim.13084. Epub 2020 May 25.

BCG scarring and improved child survival: a combined analysis of studies of BCG scarring

C S Benn  1   2   3 , A Roth  4   5 , M-L Garly  1 , A B Fisker  1   3 , F Schaltz-Buchholzer  1   3 , A Timmermann  6 , M Berendsen  1   3   7 , P Aaby  1   2
Affiliations
Free article
Review

BCG scarring and improved child survival: a combined analysis of studies of BCG scarring

C S Benn et al. J Intern Med. 2020 Dec.
Free article

Abstract

Bacillus Calmette-Guérin (BCG) vaccine against tuberculosis (TB) is recommended at birth in TB-endemic areas. Currently, BCG vaccination programmes use "BCG vaccination coverage by 12 months of age" as the performance indicator. Previous studies suggest that BCG-vaccinated children, who develop a scar, have better overall survival compared with BCG-vaccinated children, who do not develop a scar. We summarized the available studies of BCG scarring and child survival. A structured literature search for studies with original data and analysis of BCG scarring and mortality were performed. Combined analyses on the effect of BCG scarring on overall mortality. We identified six studies covering seven cohorts, all from Guinea-Bissau, West Africa, with evaluation of BCG scarring amongst BCG-vaccinated children and follow-up for mortality. Determinants of BCG scarring were BCG strain, intradermal injection route, size of injection wheal, and co-administered vaccines and micronutrients. In a combined analysis, having a BCG scar vs. no BCG scar was associated with a mortality rate ratio (MRR) of 0.61 (95% CI: 0.51-0.74). The proportion with a BCG scar varied from 52 to 93%; the estimated effect of a BCG scar was not associated with the scar prevalence. The effect was strongest in the first (MRR = 0.48 (0.37-0.62)) and second (MRR = 0.63 (0.44-0.92)) year of life, and in children BCG-vaccinated in the neonatal period (MRR = 0.45 (0.36-0.55)). The effect was not explained by protection against TB. Confounding and genetic factors are unlikely to explain the strong association between BCG scarring and subsequent survival. Including "BCG scar prevalence" as a BCG vaccination programme performance indicator should be considered. The effect of revaccinating scar-negative children should be studied.

Keywords: BCG scar; Bacille Calmette-Guérin; child survival; nonspecific effects of vaccines.

PubMed Disclaimer

References

    1. Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med 1931; 24: 1481-90.
    1. Naeslund C. Resultats Des Experiences de Vaccination Par le BCG Poursuivies Dans le Norrbotten (Suède) (Septembre 1927 - Décembre 1931). Vaccination Préventive de la Tuberculose de l'homme et des animaux par le B C G Rapports et Documents Provenant Des Divers Pays (la France exceptée) transmis à l'Institut Pasteur en 1932. Paris, France: Mason and Cie; 1932: 274-81.
    1. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000; 321: 1435-8.
    1. Garly ML, Balé C, Martins CL et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 2001; 20: 468-74.
    1. Garly ML, Martins CL, Balé C et al. BCG scar and positive tuberculin reaction and reduced infant and childhood mortality in West Africa: A non-specific beneficial effect of BCG? Vaccine 2003; 21: 2782-90.

Publication types